Unknown

Dataset Information

0

Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase.


ABSTRACT: Postnatal cartilage development and growth are regulated by key growth factors and signaling molecules. To fully understand the function of these regulators, an inducible and chondrocyte-specific gene deletion system needs to be established to circumvent the perinatal lethality. In this report, we have generated a transgenic mouse model (Col2a1-CreER(T2)) in which expression of the Cre recombinase is driven by the chondrocyte-specific col2a1 promoter in a tamoxifen-inducible manner. To determine the specificity and efficiency of the Cre recombination, we have bred Col2a1-CreER(T2) mice with Rosa26R reporter mice. The X-Gal staining showed that the Cre recombination is specifically achieved in cartilage tissues with tamoxifen-induction. In vitro experiments of chondrocyte cell culture also demonstrate the 4-hydroxy tamoxifen-induced Cre recombination. These results demonstrate that Col2a1-CreER(T2) transgenic mice can be used as a valuable tool for an inducible and chondrocyte-specific gene deletion approach.

SUBMITTER: Chen M 

PROVIDER: S-EPMC2654410 | BioStudies | 2007-01-01

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3730784 | BioStudies
2010-01-01 | S-EPMC2965077 | BioStudies
| S-EPMC5660656 | BioStudies
2020-01-01 | S-EPMC7017886 | BioStudies
2010-01-01 | S-EPMC2820209 | BioStudies
| S-EPMC3978435 | BioStudies
| S-EPMC2708938 | BioStudies
2013-01-01 | S-EPMC3581196 | BioStudies
2011-01-01 | S-EPMC3053115 | BioStudies
2012-01-01 | S-EPMC3314663 | BioStudies